Institutional Ownership Innate Pharma Sa (IPHA)
This table provides information about the institutional ownership of Innate Pharma Sa (IPHA). We have compiled data on the 10 institutions that hold shares in the stock, with a total of 81,617 shares, which have been reported (via 13F filing form) to have a value of $148,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
53,564
shares
|
$97,486
0.0% of portfolio
|
Q3 2025
Added 4.57%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
20,042
shares
|
$36,476
0.0% of portfolio
|
Q3 2025
Reduced 24.7%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
4,797
shares
|
$8,730
0.0% of portfolio
|
Q3 2025
Reduced 19.47%
|
|
|
Gamma Investing LLC
Foster City, CA |
Oct 02, 2025 Q3 2025 |
2,281
shares
|
$4,151
0.0% of portfolio
|
Q3 2025
Reduced 34.0%
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 06, 2025 Q3 2025 |
470
shares
|
$855
0.0% of portfolio
|
Q2 2025
Reduced 30.37%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
307
shares
|
$558
0.0% of portfolio
|
Q3 2024
Reduced 25.49%
|
|
|
Optiver Holding B.V.
Amsterdam, P7 |
Nov 10, 2025 Q3 2025 |
101
shares
|
$183
0.0% of portfolio
|
Q4 2024
Reduced 99.88%
|
|
|
Principal Securities, Inc.
Des Moines, IA |
Nov 12, 2025 Q3 2025 |
45
shares
|
$81
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Farther Finance Advisors, LLC
San Francisco, CA |
Oct 14, 2025 Q3 2025 |
10
shares
|
$18
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|